Conference call top-line results Phase 2/3 Illuminate trial Webcast ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10. February 11, 2022